limited partners login

Intersouth Partners

Experienced early-stage venture capital firm
  • Home
  • About Us
  • Team
  • Portfolio
  • For Entrepreneurs
  • News & Events
  • Contact
  • News
  • Events
  • Press Kit

05.14.09

Florida Institute for the Commercialization of Public Research Forms Strategic Advisory Board

Press Release

05.14.09

Cempra Pharmaceuticals Closes $46 Million Series C Financing

Press Release

05.04.09

MaxCyte to Present on Development of Novel Tumor-Targeted Enhanced Potency T Cell Immunotherapy at The 15th Annual Meeting of the International Society of Cellular Therapy (ISCT)

Press Release

05.04.09

Alimera Sciences Announces Presentation Of Data From The 12-Month Interim Readout Of The Human PK ILUVIEN™ Study At ARVO 2009 Annual Meeting

Press Release

05.04.09

Applied Genetic stays inside to guard valuation

Dow Jones VentureWire

05.04.09

Arsenal Medical armed with $8M from insiders

Dow Jones VentureWire

05.01.09

Argos Therapeutics sees new promise for immunotherapeutics

TechJournal South

05.01.09

Applied Genetic Technologies adds $11.8M round to its DNA

TechJournal South

04.28.09

Mixx Looks to Go Beyond the News

The Washington Post

04.24.09

Biolex Therapeutics Researchers Present Locteron® U.S. Phase 2a Hepatitis C Trial Results at EASL Conference

Press Release

More News: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Copyright © 2010, Intersouth Partners, Durham, North Carolina. All rights reserved. | Legal Terms